Cytokinetics CYTK Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $19.36M+1,126% | $17.76M+4.9% | $1.94M+318% | $66.77M+26,715% | $1.58M+89.1% | ||
| $95.53M-2.8% | $104.4M+11.5% | $99.23M+17.3% | $112.55M+41.4% | $98.26M+20.5% | ||
| $104.9M+82.8% | —— | —— | —— | $57.37M— | ||
| —— | $91.72M+47.1% | $69.46M+22.6% | $65.72M+29.3% | $57.37M+26.1% | ||
| $202.97M+29.1% | $196.12M+25.7% | $168.69M+19.4% | $178.28M+36.7% | $157.21M+23.7% | ||
| -$183.62M-18.0% | -$178.37M-28.3% | -$166.76M-18.4% | -$111.51M+14.3% | -$155.63M-23.3% | ||
| -948.7%+8,908pp | -1,004.6%-183pp | -8,613.4%+21,797pp | -167%+52,111pp | -9,856.3%+5,262pp | ||
| $14.52M+63.7% | $14.27M+59.7% | $11.35M+27.2% | $11.08M-12.9% | $8.87M+24.8% | ||
| $11.02M-19.6% | $11.47M-23.6% | $10.25M-39.9% | $13M+12.5% | $13.7M+73.1% | ||
| -$206.03M-27.7% | -$183.03M-22.0% | -$306.18M-90.7% | -$134.37M+6.2% | -$161.38M-19.0% | ||
| -1,064.5%+9,156pp | -1,030.9%-145pp | -15,815%+18,860pp | -201.2%+57,356pp | -10,220.1%+6,025pp | ||
| -$1.67-22.8% | -$1.50-19.0% | -$2.55-87.5% | -$1.12+14.5% | -$1.36-2.3% | ||
| -$180.24M-17.5% | -$175.51M-28.4% | -$164.08M-18.6% | -$109.22M+14.5% | -$153.33M-23.7% | ||
| -931.2%+8,779pp | -988.5%-181pp | -8,475%+21,415pp | -163.6%+51,148pp | -9,710.6%+5,128pp | ||
| -$183.62M-18.0% | -$178.37M-28.3% | -$166.76M-18.4% | -$111.51M+14.3% | -$155.63M-23.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Cytokinetics's revenue?
- Cytokinetics (CYTK) generated $105.8M in revenue over the trailing twelve months, up 450.6% year over year.
- Is Cytokinetics profitable?
- Cytokinetics is not currently profitable: it reported a net loss of $829.6M over the trailing twelve months, a -784.0% net margin.
- What is Cytokinetics's earnings per share?
- Cytokinetics's diluted EPS over the trailing twelve months is $-6.84.
- Where does Cytokinetics's income statement data come from?
- Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
